UnitedHealth stock tests support at $397.8 as downside pressures linger: weekly analysis

Traders Union
All News
Stocks
Unitedhealth group slips 0.83% this week

Highlights

Shares of UnitedHealth fell to $403.77 this week, slipping below key short-term averages while holding above the long-term level.
Technical indicators show a developing downside trend with MACD and ADX at sell signals and momentum yet to confirm further direction.
Shares are projected to trade between $395.19 and $436.26 next week, with resistance at $413.18 and support at $397.8.

Upbeat outlook as robust results and guidance upgrade lift sentiment

UnitedHealth posted its second-quarter 2026 results, revealing stronger-than-expected revenue and earnings for the period ended June 30, 2026, according to filing details from kalkinemedia.com and the Securities and Exchange Commission. As a result, the company raised its full-year adjusted EPS guidance to $19.50–$20.00, according to Yahoo Finance and Quiver Quantitative. News from Yahoo Finance and Simply Wall St also highlighted UnitedHealth's $4 million pledge through the United Health Foundation to triple the University of Tennessee Health Sciences’ health hub network by the end of 2027, while State Street disclosed a 5% stake in UNH in a recent SEC filing.

Weakening technical setup as signals diverge and volatility persists over the week

The daily chart structure features a developing trend, with momentum characterized by an emerging move lower that is not yet confirmed. MACD and ADX both signal sell, while RSI holds in the neutral zone at 45.37, pointing to a lack of clear conviction. With volatility over the past week at 4.82%, the stock currently finds support at $397.8 and faces resistance at $413.18, with the Ichimoku Kijun at $429.71 also acting as a barrier. This positioning suggests downside pressures are building, but a decisive move is still awaited.

Range-bound trade expected next week amid downside risks and breakout potential

Next week, UnitedHealth is expected to trade between $395.19 and $436.26, with a 55% probability of a decrease and 45% for an increase. The base case keeps the stock ranging between support at $397.8 and resistance at $413.18. A bullish scenario unfolds if shares move decisively above $413.18 toward the upper boundary of the expected range. Conversely, a drop below $397.8 would open up further downside risk within the forecasted levels.

Sholanke Dele, market strategist, sees this week’s action in UnitedHealth as confirming lingering downside pressures amid persistent uncertainty. Despite UnitedHealth raising its full-year EPS guidance and announcing fresh institutional support, sentiment failed to shift meaningfully, with technical indicators showing bearish momentum and no confirmation of reversal. He remains cautious as the stock sits in a vulnerable zone just above support at $397.8, lacking conviction for a clear breakout. "Until bulls reclaim $413.18, I see little reason to expect an upside reversal in the coming week."

Earlier, analysts noted that healthcare’s relative strength and robust earnings prospects were driving increased interest and sector rotation on Wall Street. UnitedHealth’s recent earnings beat and higher full-year guidance reinforce this narrative, but with technical pressure mounting, traders should monitor for a confirmed break above $413.18 or below $397.8 to determine the stock’s next direction.

Source of Data: UNH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.